UNITY color transp BG.jpg
UNITY Biotechnology, Inc. Reports Second Quarter 2020 Financial Results and Clinical Program Updates
31 juil. 2020 07h57 HE | Unity Biotechnology, Inc.
SOUTH SAN FRANCISCO, Calif., July 31, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing,...
UNITY color transp BG.jpg
UPDATE – UNITY Biotechnology, Inc. to Announce Second Quarter 2020 Financial Results
29 juil. 2020 16h05 HE | Unity Biotechnology, Inc.
SAN FRANCISCO, July 29, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...
UNITY color transp BG.jpg
UNITY Biotechnology, Inc. to Announce Second Quarter 2020 Financial Results
24 juil. 2020 08h00 HE | Unity Biotechnology, Inc.
SAN FRANCISCO, July 24, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...
UNITY color transp BG.jpg
UNITY Biotechnology Announces CFO Transition
06 juil. 2020 17h00 HE | Unity Biotechnology, Inc.
SAN FRANCISCO, July 06, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY color transp BG.jpg
UNITY Biotechnology, Inc. Provides Updates on Lead Development Programs
01 juil. 2020 16h05 HE | Unity Biotechnology, Inc.
– Topline 12-week results for Phase 2 study of UBX0101 in osteoarthritis expected in 3Q 2020 – – First-in-human study for UBX1325 in age-related eye disease expected to commence in 2H 2020 – SOUTH...
UNITY color transp BG.jpg
UNITY Biotechnology, Inc. Reports First Quarter 2020 Financial Results and Business Updates
07 mai 2020 16h05 HE | Unity Biotechnology, Inc.
SOUTH SAN FRANCISCO, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting...
UNITY color transp BG.jpg
UNITY Biotechnology, Inc. to Announce First Quarter 2020 Financial Results
04 mai 2020 16h30 HE | Unity Biotechnology, Inc.
SAN FRANCISCO, May 04, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...
UNITY color transp BG.jpg
UNITY Biotechnology Completes Enrollment in Phase 1b Study of UBX0101
31 mars 2020 16h05 HE | Unity Biotechnology, Inc.
SAN FRANCISCO, March 31, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY color transp BG.jpg
UNITY Biotechnology Announces Start of New CEO and New Employment Inducement Grants
30 mars 2020 17h20 HE | Unity Biotechnology, Inc.
SOUTH SAN FRANCISCO, Calif., March 30, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. today announced that Anirvan Ghosh, Ph.D., has officially joined the company as Chief Executive Officer. As...
UNITY color transp BG.jpg
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results
11 mars 2020 16h05 HE | Unity Biotechnology, Inc.
SOUTH SAN FRANCISCO, Calif., March 11, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing,...